[ Price : $8.95]
FDA places a partial clinical hold on a MacroGenics Phase 2 (LINNET) trial of its investigational immunotherapy lorigerlimab after...[ Price : $8.95]
Attorney Grant Hollingsworth outlines Trump administration changes that could positively or negatively affect a preemption defense...[ Price : $8.95]
FDA cites significant data integrity and quality control failures at an Indian manufacturing facility operated by Aurobindo Pharma...[ Price : $8.95]
FDA accepts the Sibel Aria cough sensor into its Drug Development Tool qualification program.[ Price : $8.95]
FDA accepts for review a Genentech NDA for giredestrant for treating patients with endocrine-resistant breast cancer.[ Price : $8.95]
A Maryland federal judge dismisses a physicians bid to force FDA to create a special, conditional access pathway for certain exper...[ Price : $8.95]
FDA accepts for priority review a Savara BLA for Molbreevi as a treatment for autoimmune pulmonary alveolar proteinosis.[ Price : $8.95]
CDER acting director Tracy Beth Hoeg says the Center is preparing new safety reviews of widely used antidepressants and monoclonal...